i-Optics

i-Optics

Signal active

Organization

Contact Information

Overview

i-Optics pioneers smart and superior eye diagnosis solutions that are affordable, fast and user-friendly for care providers worldwide to serve their patients best. Its innovations include: • Cassini – A first-of-its-kind Corneal Shape Analyzer based on Color LED Technology. Cassini measures the true axis and magnitude of corneal astigmatism and is essential for premium IOL planning. Put an end to unexpected refractive outcomes for your astigmatic cataract patients with Cassini from i-Optics. • EasyScan – A breakthrough, zero-dilation retinal imaging system that uses SLO technology to diagnose retinal diseases including diabetic retinopathy, age-related macular degeneration (AMD) and glaucoma.

About

Industries

Biotechnology, Product Design, Health Diagnostics

Founded

2007

Employees

1-10

Headquarters locations

Europe

Social

N/A

Profile Resume

i-Optics headquartered in Europe, operates in the Biotechnology, Product Design, Health Diagnostics sector. The company focuses on Biotechnology and has secured $1.3B in funding across 36 round(s). With a team of 1-10 employees, i-Optics is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - i-Optics, raised $5.8M. Discover more about their projects, partnerships, and impact on our platform.

Employees

N/A

Funding Rounds

Funding rounds

3

Investors

3

Lead Investors

0

Total Funding Amount

$36.1M

Details

2

i-Optics has raised a total of $36.1M in funding over 2 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2013Late Stage Venture15.1M
2010Late Stage Venture5.8M

Investors

i-Optics is funded by 7 investors.

Investor NameLead InvestorFunding RoundPartners
Patrick Krol-FUNDING ROUND - Patrick Krol15.1M
Aescap Venture-FUNDING ROUND - Aescap Venture15.1M
i-Optics-FUNDING ROUND - i-Optics15.1M
IPF Partners-FUNDING ROUND - IPF Partners15.1M

Recent Activity

There is no recent news or activity for this profile.